Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...

While its Hugo surgical robot undergoes review at the FDA, Medtronic presented clinical data from its U.S. trial demonstrating success in hernia repairs—notably with zero mid-procedure conversions to ...

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...

Medtronic’s Hugo robotic-assisted surgery system receives US FDA clearance for urologic surgical procedures: Galway, Ireland ...

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) ...